Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leveraging Exosomes as the Next-Generation Bio-Shuttles: The Next Biggest Approach against Th17 Cell Catastrophe. | Int J Mol Sci | 2023 | 37108809 | PubTator, text mining | PubMed |
| Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein. | Int J Mol Sci | 2023 | 37108807 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting. | Int J Mol Sci | 2023 | 37108657 | PubTator, text mining | PubMed |
| Imaging CAR-T Synapse as a Quality Control for CAR Engineering. | Methods Mol Biol | 2023 | 37106204 | PubTator, text mining | PubMed |
| The Use of Hydrogels for the Treatment of Bone Osteosarcoma via Localized Drug-Delivery and Tissue Regeneration: A Narrative Review. | Gels | 2023 | 37102886 | PubTator, text mining | PubMed |
| Design of diversified chimeric antigen receptors through rational module recombination. | iScience | 2023 | 37102149 | PubTator, text mining | PubMed |
| Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer. | J Immunother Cancer | 2023 | 37100458 | PubTator, text mining | PubMed |
| Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation. | Blood Adv | 2023 | 37093643 | PubTator, text mining | PubMed |
| Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma. | Int J Surg | 2023 | 37093067 | PubTator, text mining | PubMed |
| Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. | Bioact Mater | 2023 | 37091063 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs. | Front Immunol | 2023 | 37090720 | PubTator, text mining | PubMed |
| Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells. | J Immunol Regen Med | 2023 | 37089616 | PubTator, text mining | PubMed |
| CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. | Med Oncol | 2023 | 37083979 | PubTator, text mining | PubMed |
| Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy. | Front Oncol | 2023 | 37081982 | PubTator, text mining | PubMed |
| CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. | Nat Commun | 2023 | 37080958 | PubTator, text mining | PubMed |
| Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches. | Curr Treat Options Oncol | 2023 | 37079257 | PubTator, text mining | PubMed |
| A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells. | Nucleic Acids Res | 2023 | 37070192 | PubTator, text mining | PubMed |
| A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor. | Nat Biomed Eng | 2023 | 37069267 | PubTator, text mining | PubMed |
| Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention. | Open Forum Infect Dis | 2023 | 37065990 | PubTator, text mining | PubMed |
| Anti-BCMA novel therapies for multiple myeloma. | Cancer Drug Resist | 2023 | 37065871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=33